Zydus Lifesciences said that it has received final approval from US Food and Drug Administration (USFDA) for Lubiprostone capsules, 8 mcg and 24 mcg.
Dr. Reddy's Generic Lubiprostone Receives Approval in the U.S.
Teva Pharms' Generic Lubiprostone Receives Approval in the U.S.
Every day seems like a new test for Mallinckrodt investors: Consider last month, when Humana took the company to court for $700 million in fraudulent billing. But now, with Mallinckrodt reportedly talking bankruptcy if federal opioid penalties balloon out of control, it could be the last straw.
Amneal Pharm`s Generic Lubiprostone Receives Tentative Approval in US
5 Biopharma Trends to Watch in 2019
With its plan for a spinoff into two companies, Mallinckrodt will create an API and generics operation with a large controlled substances and acetaminophen business and seven manufacturing facilities split between the U.S. and Japan.
Reuters) - Mallinckrodt Plc (MNK.N) plans to spin off its specialty generics business to shareholders by the second half of 2019, but said it was still open to a sale of the unit.
Enforcement Report - Week of November 21, 2018